Abstract

AbstractMechanisms of the regression of transplantated tumours in mice caused by lentinan, an anti‐tumour polysaccharide, were examined. 1) Lentinan showed a marked anti‐tumour effect when the animal was pretreated, starting 12 days before tumour inoculation. 2) The anti‐tumour effect of lentinan was blocked by injection of anti‐lymphocyte serum from 24 h after tumour transplantation. Lymphoid cells attacked by this serum apparently play an important role in tumour regression induced by lentinan. 3) Considering the selective actions of anti‐lymphocyte serum as an immunosuppressor, one of the mechanisms responsible for the anti‐tumour effect of lentinan may be the stimulation of cell‐mediated responses. 4) Humoral antibodies against lentinan do not seem to participate in tumour regression.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call